We indeed observed that TG003 decreased SRSF1 phosphorylation and induced a dose-dependent inhibition of MM cell viability, with a significant difference in the IC50 detected between MM cells and PHA-activated normal donor PBMCs (Fig. 3E and Supplementary Fig. 4C). This evidence concerns the gene SRSF1 and Miyoshi myopathy.